Enalapril Maleate 20 mg

DRUG2 trials

Sponsors

GlaxoSmithKline, Omar Tarek Elfarargi

Conditions

Diabetic Nephropathy Type 2Hypertension

Phase 1

A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study

CompletedNCT01822639

GlaxoSmithKlineHypertension

Start: 2013-04-03End: 2013-05-24Updated: 2017-06-05

Phase 2

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease

Omar Tarek ElfarargiDiabetic Nephropathy Type 2

Start: 2023-03-31End: 2024-05-31Target: 212Updated: 2022-05-13